Skip to main content
Journal cover image

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study

Publication ,  Journal Article
Gradishar, WJ; Meza, LA; Amin, B; Samid, D; Hill, T; Chen, YM; Lower, EE; Marcom, PK; Iqbal, S
Published in: Women's Oncology Review
December 1, 2004

Duke Scholars

Published In

Women's Oncology Review

DOI

ISSN

1473-3404

Publication Date

December 1, 2004

Volume

4

Issue

4

Start / End Page

283 / 285
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Meza, L. A., Amin, B., Samid, D., Hill, T., Chen, Y. M., … Iqbal, S. (2004). Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study. Women’s Oncology Review, 4(4), 283–285. https://doi.org/10.1080/14733400500034472
Gradishar, W. J., L. A. Meza, B. Amin, D. Samid, T. Hill, Y. M. Chen, E. E. Lower, P. K. Marcom, and S. Iqbal. “Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study.” Women’s Oncology Review 4, no. 4 (December 1, 2004): 283–85. https://doi.org/10.1080/14733400500034472.
Gradishar WJ, Meza LA, Amin B, Samid D, Hill T, Chen YM, et al. Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study. Women’s Oncology Review. 2004 Dec 1;4(4):283–5.
Gradishar, W. J., et al. “Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study.” Women’s Oncology Review, vol. 4, no. 4, Dec. 2004, pp. 283–85. Scopus, doi:10.1080/14733400500034472.
Gradishar WJ, Meza LA, Amin B, Samid D, Hill T, Chen YM, Lower EE, Marcom PK, Iqbal S. Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study. Women’s Oncology Review. 2004 Dec 1;4(4):283–285.
Journal cover image

Published In

Women's Oncology Review

DOI

ISSN

1473-3404

Publication Date

December 1, 2004

Volume

4

Issue

4

Start / End Page

283 / 285